Among antipsychotics, prolactin-raising (PR) antipsychotics, are more likely to influence BMD of patients, due to antipsychotic-induced hyperprolactinemia and/or secondary hypogonadism9,10. This evidence concerns the gene PRL and hyperprolactinemia.